We provide actionable market intelligence to support your entry decisions — including competitive landscape mapping, tender price benchmarking, channel analysis (hospital vs. retail), and patient population sizing for your target therapy areas. Our data draws on various market reports and proprietary field insights across the country.
With experience spanning both the hospital (ETC) and retail (OTC) channels, we offer customised commercial strategies for each stage of your product life cycle — from pre-launch feasibility through to portfolio expansion and lifecycle management.
Our regulatory affairs team, built over 27 years, manages the full DAV registration process including dossier preparation, SRA-reference pathway applications, price declaration to DOH/DAV. We also provide ongoing pharmacovigilance support and keep your registrations current through regulatory amendments.
We advise on tender group positioning under Vietnam's five-group GMP classification system — identifying whether your product qualifies for Group 1 to Group 5, and developing a pricing and positioning strategy accordingly. We also manage hospital Drug and Therapeutics Committee (DTC) submissions to secure formulary inclusion at priority facilities.
083842 1834